Natera, Inc. Business Finance Contracts & Agreements

18 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement dated as of September 6, 2023, by and among Natera, Inc. and Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Cowen and Company, LLC, and Piper Sandler &...
Underwriting Agreements
Natera, Inc.
Biotechnology
CA
2023
Underwriting Agreement dated as of November 15, 2022, among Natera, Inc. and Morgan Stanley & Co. LLC, Cowen and Company, LLC, and SVB Securities LLC, as representatives of the...
Underwriting Agreements
Natera, Inc.
Biotechnology
CA
2022
Underwriting Agreement dated as of July 21, 2021, among Natera, Inc. and Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Cowen and Company, LLC and SVB Leerink LLC, as...
Underwriting Agreements
Natera, Inc.
Biotechnology
CA
2021
Description of Common Stock
Stock Agreements
Natera, Inc.
Biotechnology
2021
Underwriting Agreement dated as of September 10, 2020, among Natera, Inc. and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Cowen and Company, LLC and SVB Leerink LLC as...
Underwriting Agreements
Natera, Inc.
Biotechnology
CA
2020
Indenture (including form of Note) with respect to the Companys 2.25% Convertible Senior Notes due 2027, dated as of April 16, 2020, between the Company and Wilmington Trust,...
Indenture Agreements
Natera, Inc.
Biotechnology
DE
2020
Description of Common Stock
Stock Agreements
Natera, Inc.
Biotechnology
2020
Third Amendment to Credit Agreement, dated September 12, 2019, by and between Natera, Inc. and Orbimed Royalty Opportunities II, LP
Credit Agreements
Natera, Inc.
Biotechnology
NY
2019
Underwriting Agreement dated as of October 16, 2019, among Natera, Inc. and J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, as representatives of the underwriters named...
Underwriting Agreements
Natera, Inc.
Biotechnology
CA
2019
Second Amendment to Credit Agreement, dated April 15, 2019, by and between Natera, Inc. and Orbimed Royalty Opportunities II, LP
Credit Agreements
Natera, Inc.
Biotechnology
NY
2019
Underwriting Agreement dated as of April 17, 2019, among Natera, Inc. and J.P. Morgan Securities LLC, Cowen and Company, LLC, and Piper Jaffray & Co. as representatives of the...
Underwriting Agreements
Natera, Inc.
Biotechnology
CA
2019
Amendment and Waiver to Credit Agreement, dated as of December 31, 2018, by and between Natera, Inc. and OrbiMed Royalty Opportunities II, LP
Credit Agreements
Natera, Inc.
Biotechnology
NY
2019
Form of Underwriting Agreement dated as of July 12, 2018, among Natera, Inc. and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and Cowen and Company, LLC, as...
Underwriting Agreements
Natera, Inc.
Biotechnology
NY
2018
NATERA, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED EFFECTIVE AS OF THE DATE OF THE INITIAL PUBLIC OFFERING)
Stock Agreements
Natera, Inc.
Biotechnology
DE
2015
NATERA, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED EFFECTIVE AS OF THE DATE OF THE INITIAL PUBLIC OFFERING)
Stock Agreements
Natera, Inc.
Biotechnology
DE
2015
[ ] Shares NATERA, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Natera, Inc.
Biotechnology
CA
2015
NATERA, INC. 2007 STOCK PLAN ADOPTED ON JANUARY 26, 2007 AND AMENDED ON JUNE 7, 2007
Stock Agreements
Natera, Inc.
Biotechnology
DE
2015
NATERA, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT November 20, 2014
Investor Rights Agreements
Natera, Inc.
Biotechnology
DE
2015